Eleanor Cole retweeted
[2022 Neuromodec Highlights in Neuromodulation] "Stanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant Depression" by @EleanorJCole @NolanRyWilliams @BrandonBentzley @RominaNejad @EspilPhD
All highlights👉neuromodec.org/2022-neuromod…
Eleanor Cole retweeted
New Huberman Lab Podcast out: PSYCHEDELICS & NEUROSTIMULATION FOR REWIRING THE BRAIN w/Dr Nolan Williams MD
@NolanRyWilliams of @StanfordMed
• Treating Depression
• TMS
• Ibogaine, MDMA, DMT, LSD
• Psylocibin, Cannabis, SSRIs
• Safety, Risks, Etc.
hubermanlab.com/dr-nolan-wil…
Eleanor Cole retweeted
Psych News Alert: FDA Clears Novel, Rapid-Acting TMS System for Treatment-Resistant Depression: alert.psychnews.org/2022/09/…
Eleanor Cole retweeted
Four articles published in 2021 by The American Journal of Psychiatry have been honored by @BBRFoundation as 2021 Leading Research Achievements for notable contributions to research on mental illness and the biology of the brain.
Read more: psychiatry.org/newsroom/news…
Eleanor Cole retweeted
An enhanced form of non-invasive #brain stimulation called SNT generated "a large #antidepressant effect" that brought remission to 79% of treatment-resistant #depression patients within 4 weeks of a 5-day treatment course. ow.ly/wThn50GLw2H
Eleanor Cole retweeted
Many thanks to @CBSSunday for a great interview. I would also like to thank the team that have worked so very hard to make SAINT a reality (@EleanorJCole, @BrandonBentzley, @Stanford_BSL). @standfordmed @Stanford @StanfordPSY
ajp.psychiatryonline.org/doi…
Depression remains the leading cause of disability worldwide, affecting almost 300 million people, half of whom can't find lasting relief from drugs or therapy. However, a new experimental treatment seems to be hopeful cbsn.ws/2ZU8OjB
A new treatment for depression
Eleanor Cole retweeted
Brain stimulation world- don’t miss this great article from @EleanorJCole @NolanRyWilliams High density TMS (iTBS 1800, 90% rMT, 5 days, 10 sessions/day) led to remission in 78% (active) vs 13% (sham/placebo) in a cohort of MDD + suicidal inpatients
Double-blind RCT of Stanford Neuromodulation Therapy (SNT) is out in AJP. Thank you to the amazing team for making this happen, I am excited for the future of neuromodulation in psychiatry: ajp.psychiatryonline.org/doi…
Eleanor Cole retweeted
Our team showed that nearly all very depressed patients get dramatically better w just 5 days of a new kind of treatment. This is truly game-changing.
Great work, teammates at @StanfordPSY: @NolanRyWilliams @KristinRajMD @EleanorJCole @EspilPhD et. al.!
ajp.psychiatryonline.org/doi…
Eleanor Cole retweeted
Proud to share that the FDA granted Breakthrough Device Designation for our individualized, non-invasive, investigational #neuromodulation technology for people with major #depression. ow.ly/oE7K50GB34n
#innovation #fMRI #targeted #brainhealth
Double-blind RCT of Stanford Neuromodulation Therapy (SNT) is out in AJP. Thank you to the amazing team for making this happen, I am excited for the future of neuromodulation in psychiatry: ajp.psychiatryonline.org/doi…
Eleanor Cole retweeted
So happy to have this #TMS #OCD paper out - a true multidisciplinary effort! Although preliminary, it opens up new therapeutic avenues for #OCD Thank you @nolanrywilliams , Keith Sudheimer and @EleanorJCole for leading this team! @StanfordPSY @brainstimj @IOCDF #brainstimulation
Our new open-label trial suggests safety, feasibility, and high efficacy for treatment-refractory OCD of an accelerated, fMRI-guided, high-dose, cTBSmod protocol targeting right frontal pole. @brainstimj @EleanorJCole @Stanford_PMHW @CRodriguezMDPhD doi.org/10.1016/j.brs.2021.0…
Pilot study of accelerated, fMRI-guided cTBS(mod) for OCD, now available online in @brainstimj: brainstimjrnl.com/article/S1…. @CRodriguezMDPhD @NolanRyWilliams
Eleanor Cole retweeted
US employers cut 140,000 jobs in December, according to the latest jobs report. Women accounted for all the losses, losing 156,000 jobs, while men gained 16,000. cnn.it/38tgBGW
Great panel for the second day of the BrainBox Initiative Conference including keynote by @brainstimgrl. #BBIConf2020. @Brainbox_Init
Eleanor Cole retweeted
Introducing Dr Eleanor Cole of Stanford University as an early-career speaker at the Brainbox Initiative Conference 2020. Eleanor will be giving a talk on 'Optimizing TMS for Treatment-Resistant Depression' on September 23rd.
Find out more here: brainbox-initiative.com/dr-e…
Eleanor Cole retweeted
Dr Eleanor Cole of Stanford University will be joining us at the Brainbox Initiative Conference 2020 as one of our early-career speakers discussing her research using transcranial magnetic stimulation.
View more conference info and register here: brainbox-initiative.com/brai…
Eleanor Cole retweeted
A variant of intermittent theta-burst stimulation, with stimulation guided by brain imaging data, shows promise for patients with treatment-resistant depression.
Learn More: bit.ly/2xaA7Is

























